Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in hospitalized patients with COVID-19
IRCT20210426051090N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Elevated liver enzymes, Disease prognosis and 7 more. Started Jun 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210426051090N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210426051090N1.